One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2021-147891
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 2 |
Affiliation: The University of Texas MD Anderson Cancer Center, Willamette Valley Cancer Institute and Research Center, Seagen (United States), The US Oncology Network, University of Tennessee at Knoxville, University of Tennessee Medical Center, Kadlec Clinic, San Antonio Military Medical Center, Joint Base San Antonio, University of Colorado Health, Sarah Cannon, Tennessee Oncology, University Hospitals Seidman Cancer Center, Oncology Hematology Care, Hackensack Meridian HealthBrentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine (AN+AD) for Advanced Stage Classic Hodgkin Lymphoma: Preliminary Safety Results from the Single-Arm Phase 2 Study (SGN35-027 Part B)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
